NCT02901405

Negative Pressure Dressing Therapy in Soft Tissue Sarcoma Surgery

Negative Pressure Dressings Versus Non-negative Pressure Dressing for Wound Care Following Soft Tissue Sarcoma Excision

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 17 (actual)
• Sponsor: NHS Greater Glasgow and Clyde · Academic / Other
• Sex: All
• Age: 16 Years
• Healthy volunteers: Not accepted

Summary

This randomised controlled trial aims to evaluate the difference in surgical site infection following excision of soft tissue sarcomas. The intervention is a negative wound pressure therapy dressing for 120 hours, the control is standard absorbent dressings

Detailed description

Hypothesis: The application of a negative pressure wound therapy (NPWT) dressing will reduce rates of wound breakdown in patients with resection of soft tissue sarcomas which are primarily closed. Patients will be randomised into either NPWT or standard absorbent dressings with primary outcome measure of surgical site infection according to the Health Protection Agency guidance. Secondary outcomes are; time to wound dryness, delayed discharge from hospital, adverse events, cost estimation

Conditions

• Sarcoma
• Wound Infection

Interventions

Type	Name	Description
DEVICE	Negative Pressure Wound Therapy (ActivVAC, KCI)
DEVICE	Standard dressings	Current absorbent dressing is 'tegaderm with absorbent pad' (3M)

Timeline

• Start date: 2016-10-18
• Primary completion: 2020-04-28
• Completion: 2020-04-28
• First posted: 2016-09-15
• Last updated: 2021-11-26

Locations

1 site across 1 country: United Kingdom